The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor cell RNA biomarker for bavdegalutamide (ARV-110) in metastatic castration-resistant prostate cancer without AR T878/H875 mutations.
 
Keisuke Otani
No Relationships to Disclose
 
Xin Gao
Consulting or Advisory Role - ADC Therapeutics; Arvinas; Bayer; Flare Therapeutics; Hinova Pharmaceuticals; Loxo/Lilly
Research Funding - ALX Oncology (Inst); Aprea Therapeutics (Inst); Aravive (Inst); Arvinas (Inst); Bayer (Inst); Exelixis (Inst); Harpoon therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Pfizer (Inst); Poseida therapeutics (Inst); Regeneron (Inst); Takeda (Inst); TopAlliance BioSciences Inc (Inst)
 
Erika Kusaka
No Relationships to Disclose
 
Priscilla Badusi
No Relationships to Disclose
 
Yukako Otani
No Relationships to Disclose
 
Megan Carney
No Relationships to Disclose
 
Douglas Kauff
No Relationships to Disclose
 
Kara Olivier
Honoraria - Bayer
 
Erika Meneely
No Relationships to Disclose
 
Rojer Ranjit
No Relationships to Disclose
 
Matthew Smith
No Relationships to Disclose
 
M. Dror Michaelson
No Relationships to Disclose
 
Philip Saylor
No Relationships to Disclose
 
Richard Lee
Consulting or Advisory Role - exelixis; Janssen Oncology
Research Funding - Janssen
Expert Testimony - Boehringer Ingelheim
 
David Miyamoto
No Relationships to Disclose